Canadian cannabis LP #1 in TSX Venture 50's top performing companies

BC-based medical cannabis producer, Aleafia Health, has been ranked number one in its category on the TMX Group’s 2019 TSX Venture 50 top performing company of the year.

Falling under the Clean Technology & Life Sciences category, Aleafia Health ranked ahead of its competitors. The only other cannabis company to make the list was OrganiGram Holdings, another licensed producer of medical pot.

“Aleafia Health’s selection as the TSX Venture 50’s top performing company is a strong validator of our executional capabilities and relentless focus on providing quality medical cannabis care to our over 50,000 patients,” said Aleafia Health Chairman Julian Fantino, in a release. “I thank our staff, physicians, patients and shareholders for their support and role in this significant achievement.”

TSX Venture 50 ranking for Clean Technology & Life Sciences.

According to the TMX Group’s website, the TSX Venture 50 is a ranking of top performers on TSX Venture Exchange over the last year. It groups 10 companies from five industry sectors. Each of the over 2,000 companies is judged on share price (the one-year share price change as of December 31, 2018), trading (one-year trading volume as of December 31, 2018), and market cap (the one-year market capitalization change as of December 31, 2018)

Aleafia Health CEO Geoff Benic said the company has had a landmark year. “In that time, we have purchased and brought our modern, automated greenhouse to a grow-ready state, launched our recreational retail and brands divisions with the Serruya Family and built a base of over 50,000 medical patients.”

According to the ranking results, Aleafia earned the spot by achieving a 107% increase in its share price, —  from $0.69 to $1.43 — a 762% in market capitalization — rising from $26,194,098 to $225,723,801 — and a total of 300,836,368 trades made of Aleafia assets over the year — this is called trading volume.

Aleafia Holdings a licensed producer of medical cannabis headquartered in BC. The company recently acquired Emblem Cannabis, another medically-focused LP based in Ontario in an all-share transaction valued at the time at approximately $173.2 million.